Cargando…
Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein
Buruli ulcer is a neglected tropical disease that is characterized by non-fatal lesion development. The causative agent is Mycobacterium ulcerans (M. ulcerans). There are no known vectors or transmission methods, preventing the development of control methods. There are effective diagnostic technique...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679648/ https://www.ncbi.nlm.nih.gov/pubmed/36426350 http://dx.doi.org/10.3389/fimmu.2022.1023558 |
_version_ | 1784834241906868224 |
---|---|
author | Ishwarlall, Tamara Z. Adeleke, Victoria T. Maharaj, Leah Okpeku, Moses Adeniyi, Adebayo A. Adeleke, Matthew A. |
author_facet | Ishwarlall, Tamara Z. Adeleke, Victoria T. Maharaj, Leah Okpeku, Moses Adeniyi, Adebayo A. Adeleke, Matthew A. |
author_sort | Ishwarlall, Tamara Z. |
collection | PubMed |
description | Buruli ulcer is a neglected tropical disease that is characterized by non-fatal lesion development. The causative agent is Mycobacterium ulcerans (M. ulcerans). There are no known vectors or transmission methods, preventing the development of control methods. There are effective diagnostic techniques and treatment routines; however, several socioeconomic factors may limit patients’ abilities to receive these treatments. The Bacillus Calmette–Guérin vaccine developed against tuberculosis has shown limited efficacy, and no conventionally designed vaccines have passed clinical trials. This study aimed to generate a multi-epitope vaccine against M. ulcerans from the major facilitator superfamily transporter protein using an immunoinformatics approach. Twelve M. ulcerans genome assemblies were analyzed, resulting in the identification of 11 CD8(+) and 7 CD4(+) T-cell epitopes and 2 B-cell epitopes. These conserved epitopes were computationally predicted to be antigenic, immunogenic, non-allergenic, and non-toxic. The CD4(+) T-cell epitopes were capable of inducing interferon-gamma and interleukin-4. They successfully bound to their respective human leukocyte antigens alleles in in silico docking studies. The expected global population coverage of the T-cell epitopes and their restricted human leukocyte antigens alleles was 99.90%. The population coverage of endemic regions ranged from 99.99% (Papua New Guinea) to 21.81% (Liberia). Two vaccine constructs were generated using the Toll-like receptors 2 and 4 agonists, LprG and RpfE, respectively. Both constructs were antigenic, non-allergenic, non-toxic, thermostable, basic, and hydrophilic. The DNA sequences of the vaccine constructs underwent optimization and were successfully in-silico cloned with the pET-28a(+) plasmid. The vaccine constructs were successfully docked to their respective toll-like receptors. Molecular dynamics simulations were carried out to analyze the binding interactions within the complex. The generated binding energies indicate the stability of both complexes. The constructs generated in this study display severable favorable properties, with construct one displaying a greater range of favorable properties. However, further analysis and laboratory validation are required. |
format | Online Article Text |
id | pubmed-9679648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96796482022-11-23 Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein Ishwarlall, Tamara Z. Adeleke, Victoria T. Maharaj, Leah Okpeku, Moses Adeniyi, Adebayo A. Adeleke, Matthew A. Front Immunol Immunology Buruli ulcer is a neglected tropical disease that is characterized by non-fatal lesion development. The causative agent is Mycobacterium ulcerans (M. ulcerans). There are no known vectors or transmission methods, preventing the development of control methods. There are effective diagnostic techniques and treatment routines; however, several socioeconomic factors may limit patients’ abilities to receive these treatments. The Bacillus Calmette–Guérin vaccine developed against tuberculosis has shown limited efficacy, and no conventionally designed vaccines have passed clinical trials. This study aimed to generate a multi-epitope vaccine against M. ulcerans from the major facilitator superfamily transporter protein using an immunoinformatics approach. Twelve M. ulcerans genome assemblies were analyzed, resulting in the identification of 11 CD8(+) and 7 CD4(+) T-cell epitopes and 2 B-cell epitopes. These conserved epitopes were computationally predicted to be antigenic, immunogenic, non-allergenic, and non-toxic. The CD4(+) T-cell epitopes were capable of inducing interferon-gamma and interleukin-4. They successfully bound to their respective human leukocyte antigens alleles in in silico docking studies. The expected global population coverage of the T-cell epitopes and their restricted human leukocyte antigens alleles was 99.90%. The population coverage of endemic regions ranged from 99.99% (Papua New Guinea) to 21.81% (Liberia). Two vaccine constructs were generated using the Toll-like receptors 2 and 4 agonists, LprG and RpfE, respectively. Both constructs were antigenic, non-allergenic, non-toxic, thermostable, basic, and hydrophilic. The DNA sequences of the vaccine constructs underwent optimization and were successfully in-silico cloned with the pET-28a(+) plasmid. The vaccine constructs were successfully docked to their respective toll-like receptors. Molecular dynamics simulations were carried out to analyze the binding interactions within the complex. The generated binding energies indicate the stability of both complexes. The constructs generated in this study display severable favorable properties, with construct one displaying a greater range of favorable properties. However, further analysis and laboratory validation are required. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9679648/ /pubmed/36426350 http://dx.doi.org/10.3389/fimmu.2022.1023558 Text en Copyright © 2022 Ishwarlall, Adeleke, Maharaj, Okpeku, Adeniyi and Adeleke https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Ishwarlall, Tamara Z. Adeleke, Victoria T. Maharaj, Leah Okpeku, Moses Adeniyi, Adebayo A. Adeleke, Matthew A. Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
title | Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
title_full | Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
title_fullStr | Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
title_full_unstemmed | Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
title_short | Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
title_sort | identification of potential candidate vaccines against mycobacterium ulcerans based on the major facilitator superfamily transporter protein |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679648/ https://www.ncbi.nlm.nih.gov/pubmed/36426350 http://dx.doi.org/10.3389/fimmu.2022.1023558 |
work_keys_str_mv | AT ishwarlalltamaraz identificationofpotentialcandidatevaccinesagainstmycobacteriumulceransbasedonthemajorfacilitatorsuperfamilytransporterprotein AT adelekevictoriat identificationofpotentialcandidatevaccinesagainstmycobacteriumulceransbasedonthemajorfacilitatorsuperfamilytransporterprotein AT maharajleah identificationofpotentialcandidatevaccinesagainstmycobacteriumulceransbasedonthemajorfacilitatorsuperfamilytransporterprotein AT okpekumoses identificationofpotentialcandidatevaccinesagainstmycobacteriumulceransbasedonthemajorfacilitatorsuperfamilytransporterprotein AT adeniyiadebayoa identificationofpotentialcandidatevaccinesagainstmycobacteriumulceransbasedonthemajorfacilitatorsuperfamilytransporterprotein AT adelekematthewa identificationofpotentialcandidatevaccinesagainstmycobacteriumulceransbasedonthemajorfacilitatorsuperfamilytransporterprotein |